Pathways driving the endocytosis of mutant and wild-type EGFR in cancer

相似書籍

• EGFR endocytosis is a novel therapeutic target in lung cancer with wild-type EGFR
  由: Jo, Ukhyun, et al.
  出版: (2014)
• Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
  由: Choughule, A, et al.
  出版: (2014)
• Prognostic analysis of patients with mutant and wild-type EGFR gene lung adenocarcinoma
  由: Zheng, Hongmei, et al.
  出版: (2019)
• Clathrin‐mediated EGFR endocytosis as a potential therapeutic strategy for overcoming primary resistance of EGFR TKI in wild‐type EGFR non‐small cell lung cancer
  由: Kim, Boyeon, et al.
  出版: (2020)
• Radiosensitivity Differences between EGFR Mutant and Wild-Type Lung Cancer Cells are Larger at Lower Doses
  由: Anakura, Mai, et al.
  出版: (2019)